Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
Holding DNTH?
Track your performance easily

Dianthus Therapeutics (DNTH) Financial Statements

286 Followers

Dianthus Therapeutics Financial Overview

Dianthus Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.541; its P/E ratio is -5.11; Dianthus Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.61. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 874.00K$ -924.00K$ 924.00K-
Gross Profit--$ -924.00K$ 924.00K-
EBIT$ -17.61M$ -17.84M$ -12.96M$ -14.76M$ -3.28M
EBITDA$ -16.98M$ -17.74M$ -12.85M-$ -3.28M
Net Income Common Stockholders$ -19.47M$ -13.75M$ 3.66M$ -14.76M$ -3.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 360.71M$ 377.04M$ 173.72M$ 189.87M$ 77.59M
Total Assets$ 368.96M$ 382.46M$ 179.41M$ 192.46M$ 78.64M
Total Debt$ 407.00K$ 497.00K$ 585.00K$ 670.00K$ 0.00
Net Debt$ -360.30M$ -376.54M$ -173.13M$ -189.20M$ -77.59M
Total Liabilities$ 10.74M$ 9.78M$ 10.54M$ 14.08M$ 4.03M
Stockholders Equity$ 358.22M$ 372.69M$ 168.87M$ 178.38M$ 74.60M
Cash Flow-
Free Cash Flow$ -14.54M$ -14.97M$ -11.86M-$ -2.67M
Operating Cash Flow$ -14.53M$ -14.94M$ -11.85M$ 17.14M$ -6.54M
Investing Cash Flow$ 1.17M$ -5.51M$ -8.24M$ -16.88M$ 18.87M
Financing Cash Flow$ -2.20M$ 217.85M$ -4.87M$ 138.44M-
Currency in USD

Dianthus Therapeutics Earnings and Revenue History

Dianthus Therapeutics Debt to Assets

Dianthus Therapeutics Cash Flow

Dianthus Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis